Minirin Spray (Desmopressin Acetate)

Desmopressin acetate, the active ingredient in Minirin Spray, is a vasopressin analog presented as a 10 µg per spray nasal spray for nasal use. It is employed to manage central diabetes insipidus and nocturnal enuresis in patients requiring antidiuretic therapy.

GNH USA supplies Minirin Spray as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution originating from the European Union market. The company adheres to stringent quality standards and provides regulatory documentation for global procurement.

Desmopressin acetate acts on the antidiuretic hormone pathway and is indicated for the following conditions:

- Central diabetes insipidus: reduces excessive urine output by enhancing water reabsorption in the kidneys. - Nocturnal enuresis: decreases nighttime bedwetting episodes by concentrating urine.

Desmopressin nasal spray may cause a range of adverse reactions.

Common Side Effects: - Nasal irritation or congestion: mild discomfort at the application site. - Headache: transient and usually mild. - Mild hyponatremia: low sodium levels without severe symptoms. - Thirst: increased sensation of dryness. - Nausea: occasional upset stomach. - Facial flushing: temporary redness of the skin.

Serious or Rare Side Effects: - Severe hyponatremia: marked sodium depletion that can lead to neurological symptoms. - Seizures: convulsive episodes associated with electrolyte imbalance. - Allergic reaction: rash, itching, or swelling. - Nasal septum perforation: rare structural damage to nasal tissue. - Water intoxication: excessive water retention causing cerebral edema.

Before prescribing Minirin Spray, clinicians should consider several safety measures.

- Assess serum sodium: check baseline levels to avoid hyponatremia. - Monitor fluid intake: advise patients to limit excessive water consumption. - Avoid concurrent antidiuretic agents: reduce risk of severe sodium loss. - Use cautiously in renal impairment: adjust monitoring frequency. - Store at room temperature: keep in the original container, protect from moisture and light.

Desmopressin acetate can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Concomitant use with other vasopressin analogs: risk of severe hyponatremia. - Combination with carbamazepine or other hyponatremia‑inducing drugs: additive effect on sodium loss. - Use with diuretics (especially thiazides): may potentiate water retention.

Moderate Interactions (Monitor Closely): - NSAIDs: may reduce renal clearance of desmopressin. - Alcohol: can increase the risk of hyponatremia. - Antidepressants (SSRIs): potential additive hyponatremia effect.